1. Managing pain in the older person
Linda Nazarko
Consultant Nurse London North West
Healthcare NHS Trust
22nd
September 2015
2. Aims and objectives
To be aware of:
The prevalence of pain in older people
Types of pain experienced
How to determine treatment options
How to assess pain in older people
The effects of aging and comorbidities
Drug interactions
How to work with the older person to
identify and manage side effects
How to improve concordance
3. What is pain?
“An unpleasant
sensory or emotional
experience
associated with actual
or potential tissue
damage or described
in terms of such
damage”
(IASP, 1994)
5. Musculoskeletal Pain
“Pain perceived within a
region of the body, and
believed to arise from the
muscles, ligaments, bones,
or joints” (IASP, 2009).
Tender, aching, stiff,
throbbing
Causes include:
Fibromyalgia, gout,
osteoarthritis, rheumatoid
arthritis, tendinitis
6. Neuropathic pain
“Pain arising as a direct consequence
of a lesion or disease affecting the
somatosensory system either at
peripheral or central level” (Haanpää
et al, 2011).
Shooting and burning, tingling &
numbness, stabbing, electric shock
like.
Alcoholism,amputation, back, leg, &
hip problems, chemotherapy,
diabetes, facial nerve problems,HIV
infection or AIDS, Multiple sclerosis,
shingles, spinal surgery
7. Visceral: Pain arising from internal organs
“True visceral pain’ arises as a diffuse
and poorly defined sensation usually
perceived in the midline of the body, at
the lower sternum or upper
abdomen”( Procacci et al, 1986).
Poorly localised, nonspecific regional
or whole-body motor responses, strong
autonomic & affective responses.
Appendicitis, bowel obstruction, cancer
pain, dysmenorrhea, indigestion,
irritable bowel syndrome, renal colic,
urinary retention
9. Determining treatment options
Be aware that not everyone likes to complain
Be alert to non verbal signs
Enquire about pain
Detailed clinical assessment of causes, types
Be alert to sensory & cognitive impairment
10. Eyesight
20% of people aged over 75 and
50% of people aged 90 and over
have sight loss (Access
Economics, 2009). Be as visible
as possible
Ensure lighting is good
Some older people with impaired
hearing lip read so ensure they
can see your face and mouth
Be receptive
11. Hearing
More than 70% of over 70
year-olds and 40% of over 50
year-olds have some form of
hearing loss (Action on Hearing Loss, 2011)
Minimise noise, be visible,
don’t cover your mouth
Speak clearly and slow down
slightly
Check that you have been
understood
12. Dementia
Be aware that the incidence of
dementia rises with age and
around 25% of 85 year olds and
50% of 90 year olds have
dementia (Knapp & Prince, 2007).
Ensure that you have picked a
time when the person is
receptive.
Take account of any cognitive or
sensory difficulties
13. The value of nursing
"Nursing is rooted from the needs of humanity
and is founded on the ideal of service. And
that, “the nurse is temporarily the
consciousness of the unconscious, the
love of life for the suicidal, the leg of the
amputee, the eyes of the newly blind, a
means of locomotion for the infant,
knowledge and confidence for the mother
and the mouthpiece for those too weak or
withdrawn to speak”
14. “Only when I move” syndrome
Be aware of the need to
check that even though
the person doesn’t have
pain now they might have
when they are active.
15. “Ten” syndrome
This is when a person
consistently rates pain at
10 even though staff
observe that it seems to
vary.
17. Use the right tools
Pictures, body maps, Abbey pain scale
Evaluate regularly
18. Age related chages
Age related changes cause reduced ability to absorb and
excrete drugs (Wooten, 2012: Miller, 2007: Miller, 2000: Nguyen & Goldfarb, 2012: Esposito et al,
2007: Mühlberg & Platt, 1999).
>Gastrointestinal motility and >gastro-intestinal blood flow
Changes in distribution of drugs due to > in muscle mass
& < in fat
> ability to metabolise drugs due to > hepatic blood flow &
liver mass
Reduced ability to excrete drugs due to decline in renal
function
Changes at molecular level that alter receptor binding and
may < or > sensitivity to particular classes of drugs.
19. Comorbidities
Cardiac failure- 12-13% over 75s
CKD -33% over 75s
Gastro-intestinal disease, peptic ulcers, oesophageal
varices, diverticular disease
Asthma- 10% over 65s
Dysphagia – 11% upwards
Dementia 25% at 85 and 50% at 90
20. How comorbidities affect treatment
Cardiac failure -NSAIDs > oedema, worsen
failure – contraindicated
Renal failure- NSAIDS nephrotoxic, opiates
and codeine with great caution
Dysphagia- soluble meds > Na, BP and
stroke risk
Dementia, tramadol, codeine, opiates, > falls
risk
Depression – anti-depressants + tramadol =
seratonin syndrome
21. Drug interactions
Remember falls risk
“Sedatives, analgesics and anti-
depressants dangerous
Opiods double risk injurious falls
Non opiods can > risk by 15-75%
Tramadol and anti-depressants
High doses, small people, > metabolism
22.
23. Concordance
40% non concordant
why?
Side effects
Worried addition
Difficulty swallowing
Forgetting to take
Unsure of then to take
How many pills
prepared to take
24. Identify and manage side effects
Explain possible side
effects
Discuss, be partners and
negotiate
Work out if its worth
managing side effects or
changing tack
Have a dialogue
25. Treating pain
1. “By mouth":
2. “By the Clock”
3. “Around the clock
4. "By the Ladder":
5. For the individual
27. Codeine metabolism
CYP2D6 responsible codeine
metabolism
Genetic differences, slow and fast
metabolisers
Ineffective in slow metabolisers
Fast metabolisers at risk of toxicity
Be alert to differences and use clinical
judgement to guide treatment.
28. Prevalence rates of CYP2D6
polymorphisms by ethnicity
Ethnicity Slow metabolisers Ultra-fast metabolisers
Western European 8–10% 1–4%
Southern European 7–10%
African 0–20% 5–30%
Eastern Asian 0–1%
Arabian Up to 20%
29. Tramadol
Tramadol centrally acting synthetic analgesic
compound (EMC, 2014).
Tramadol 100 mg = paracetamol & codeine (1000
mg/60 mg) (Kaye, 2004).
Risk factor post operative delirium (Künig et al,
2006)
Increases falls risk X10 )Costa-Dias et al,2014)
Increased risk falls, #, mortality (Gogol et al, 2014)
Use tramadol with extreme caution in older
people.
30. NSAIDS
17 million NSAID prescriptions are
issued in the UK each year
Can improve quality of life but treatment
can be risky
Co-prescription of NSAIDs, diuretics
and ACE inhibitors = > renal perfusion<
renal dysfunction
31. NSAIDS (2)
Worsen heart failure contraindicated
severe failure
Contraindicated asthma
Increased risk heart attack, heart failure
Nephrotoxic
Naproxen lower cardiac risk, higher
bleeding risk
Use NSAIDS only after careful
evaluation of individual risk
32. Opiates
Hazardous in older people
Increased risk toxicity due to renal and
hepatic changes
Start at doses 25-50% lower than in
younger adults
Monitor with great care
33. Last words
Assess to work out
what the problems
are and how to treat
Its not a pill for every
ill
Therapy and non
drug options
Sometimes a poodle
is better than a pain
killer
In acute and chronic non-malignant pain, Tramadol is metabolised by the liver and excreted by the kidneys so dosage should be adjusted in older people and those with impaired renal and liver function (Kaye, 2004: EMC, 2014).
Older people may be at greater risk of adverse effects from Tramadol than younger people. Brouquet and colleagues (2010) discuss how administration of tramadol is one of the risk factors for post-operative delirium in older people. work describes long lasting tramadol induced delirium. They comment
“Although tramadol may represent a well established safe therapy for chronic non-malignant pain in the elderly, these cases demonstrate that it should be applied with caution even in healthy subjects”
There is growing evidence of a high correlation between extensive use of central nervous system acting drugs and adverse reactions such as falls, fractures and mortality (Gogol et al, 2014). reviewed falls risk in relation to medication in older people who had been admitted to hospital. They found that the falls risk was ten times higher in patients who were receiving central nervous system acting drugs.
More than . These can make a real difference to a person’s quality of life but such treatment is not without risk. NSAIDs increase the risks of gastric bleeding. They should not be prescribed with anti-coagulants as this increases bleeding risk. in older patients can be a recipe for disaster as this can affect renal perfusion and renal dysfunction and cause renal impairment. If they are used a proton-pump inhibitor (PPI) should be prescribed to reduce the risks of ulceration (Patient Plus, 2015). They can worsen heart failure and are contraindicated in patients with severe heart failure (EMA, 2015).
NSAIDS increase the risks of heart problems. A large study examined 353,000 patient records from 639 separate clinical trials to assess the impact of NSAIDS. They looked at the risk of heart problems in people taking 150mg diclofenac or 2,400mg ibuprofen each day. Two thirds of NSAID prescriptions are for ibuprofen or diclofenac. They showed that for every 1,000 people taking the drugs there would be three additional heart attacks, four more cases of heart failure and one death every year. The risks are greater in people who are overweight, smoke or are at high risk of heart disease (.Coxib and traditional NSAID Trialists (CNT) Collaboration,2013). Naproxen another NSAID has lower cardiac risks than ibuprofen or diclofenac and is now being prescribed more frequently in an effort to reduce these risks. Naproxen unfortunately causes more gastric irritation that diclofenac or ibuprofen. Some people however may find diclofenac or ibuprofen is most effective and can make an informed choice about treatment risks.
NSAIDs are nephrotoxic and should be used with great caution in those with renal impairment (Curiel & Katz, 2013).
Use NSAIDS only after careful evaluation of individual risk factors, in the smallest possible dose for the shortest possible time and monitor carefully.
and age related changes to the renal and hepatic system mean that the older person is at greater risk of toxicity. When opiates are clinically required they should be started at doses 25-50% lower than in younger patients (Chau et al, 2008).